Kistler-Tiffany Companies’s VanEck Biotech ETF BBH Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2023
Q2
$74.1K Hold
475
0.01% 436
2023
Q1
$77K Hold
475
0.01% 389
2022
Q4
$75.9K Buy
475
+2
+0.4% +$317 0.02% 374
2022
Q3
$67K Hold
473
0.02% 339
2022
Q2
$69K Hold
473
0.02% 334
2022
Q1
$77K Hold
473
0.01% 337
2021
Q4
$90K Sell
473
-8
-2% -$1.54K 0.02% 307
2021
Q3
$97K Sell
481
-61
-11% -$12.8K 0.02% 280
2021
Q2
$109K Hold
542
0.03% 263
2021
Q1
$95K Hold
542
0.02% 251
2020
Q4
$92K Buy
542
+2
+0.4% +$329 0.03% 236
2020
Q3
$88K Hold
540
0.03% 227
2020
Q2
$88K Buy
540
+9
+2% +$1.37K 0.03% 209
2020
Q1
$74K Hold
531
0.03% 223
2019
Q4
$74K Buy
531
+2
+0.4% +$263 0.03% 227
2019
Q3
$62K Hold
529
0.02% 233
2019
Q2
$68K Hold
529
0.03% 229
2019
Q1
$68K Hold
529
0.03% 223
2018
Q4
$59K Buy
529
+2
+0.4% +$242 0.03% 215
2018
Q3
$72K Hold
527
0.03% 216
2018
Q2
$63K Hold
527
0.03% 223
2018
Q1
$63K Hold
527
0.03% 238
2017
Q4
$66K Buy
527
+2
+0.4% +$255 0.03% 240
2017
Q3
$70K Hold
525
0.03% 235
2017
Q2
$66K Hold
525
0.03% 232
2017
Q1
$62K Hold
525
0.03% 231
2016
Q4
$56K Buy
525
+1
+0.2% +$109 0.03% 235
2016
Q3
$60K Hold
524
0.03% 236
2016
Q2
$54K Buy
+524
New +$55.9K 0.03% 242

Other funds holding BBH

Kistler-Tiffany Companies's BBH Position: Q2 2023 in Review

Kistler-Tiffany Companies held its VanEck Biotech ETF (BBH) position steady in Q2 2023 at 475 shares worth $74.1K. The position accounts for 0.01% of the portfolio, ranked #436.

Kistler-Tiffany Companies first reported a position in BBH in Q2 2016 and has held it in 29 quarters since. The position peaked at $109K in Q2 2021. 111 funds tracked by Wall St. Rank hold BBH as of Q2 2023.

  • Kistler-Tiffany Companies held 475 shares of VanEck Biotech ETF worth $74.1K as of Q2 2023.
  • Kistler-Tiffany Companies left its VanEck Biotech ETF share count unchanged in Q2 2023.
  • VanEck Biotech ETF made up 0.01% of Kistler-Tiffany Companies's portfolio in Q2 2023, its #436 holding.
  • Kistler-Tiffany Companies first reported a position in VanEck Biotech ETF in Q2 2016 and has held it in 29 quarters since.
  • Kistler-Tiffany Companies's VanEck Biotech ETF position peaked at $109K in Q2 2021.
  • 111 funds tracked by Wall St. Rank held VanEck Biotech ETF as of Q2 2023.

Based on Kistler-Tiffany Companies's 13F filing for Q2 2023, filed 1 Aug 2023.